Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
<p>Related to Figure 2 - SMS-CTR</p>
محفوظ في:
مواد مشابهة
-
Supplemental Data File S3 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
حسب: Katie E. Hebron (15046889)
منشور في: (2025) -
Supplementary Data File S1 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
حسب: Katie E. Hebron (15046889)
منشور في: (2025) -
Supplementary Data File S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
حسب: Katie E. Hebron (15046889)
منشور في: (2025) -
Supplementary Data File S7 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
حسب: Katie E. Hebron (15046889)
منشور في: (2025) -
Supplementary Data File S8 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
حسب: Katie E. Hebron (15046889)
منشور في: (2025)